Question 1

What is Oramed Pharmaceuticals Inc.'s WACC?

Accepted Answer

Oramed Pharmaceuticals Inc. (ORMP) has a Weighted Average Cost of Capital (WACC) of 7.27%. This is calculated using a Cost of Equity of 9.03% (via CAPM with a beta of 1.19) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 75.08% in the capital structure.

Question 2

Is Oramed Pharmaceuticals Inc.'s WACC high or low?

Accepted Answer

Oramed Pharmaceuticals Inc.'s WACC of 7.27% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Oramed Pharmaceuticals Inc.'s WACC calculated?

Accepted Answer

Oramed Pharmaceuticals Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 9.03% is derived from the CAPM model using a beta of 1.19. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 75.08% equity and 24.92% debt.

Oramed Pharmaceuticals Inc. (ORMP) — WACC 分析

WACC 构成

解读

Oramed Pharmaceuticals Inc.（ORMP）WACC：7.27%

WACC计算器

Oramed Pharmaceuticals Inc.（ORMP） WACC 解读

ORMP 公司分析

ORMP DCF 估值

继续做同行对比